Moleculin Biotech

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MBRX and other ETFs, options, and stocks.

About MBRX

Moleculin Biotech, Inc. is a clinical stage pharmaceutical company, which engages in the development of treatments for highly resistant cancers and viruses. Its clinical stage drugs include Annamycin, an Anthracycline being studied for the treatment of relapsed or refractory acute myeloid leukemia (AML), and WP1066, an Immune/Transcription Modulator targeting brain tumors, pancreatic cancer, and AML. 

CEO
Walter V. Klemp
CEOWalter V. Klemp
Employees
21
Employees21
Headquarters
Houston, Texas
HeadquartersHouston, Texas
Founded
2015
Founded2015
Employees
21
Employees21

MBRX Key Statistics

Market cap
36.50M
Market cap36.50M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
126.02K
Average volume126.02K
High today
$1.30
High today$1.30
Low today
$1.23
Low today$1.23
Open price
$1.27
Open price$1.27
Volume
82.57K
Volume82.57K
52 Week high
$2.33
52 Week high$2.33
52 Week low
$0.817
52 Week low$0.817

MBRX Earnings

-$0.30
-$0.20
-$0.10
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated
per share
Estimated per share
Actual
Expected Mar 23, After Hours
ActualExpected Mar 23, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.